Researchers discover test to predict which patients with rare blood disease will respond to only FDA-approved treatment, and identify alternative therapy — ScienceDaily
New research has uncovered a precision medicine test using blood proteins to identify a novel patient subgroup of idiopathic multicentric Castleman disease (iMCD), a rare blood disorder, who are more…
